Categories: ChildrenFeatureNews

ALL ABOUT VISION RELEASES COMPREHENSIVE INFORMATION HUB IN RESPONSE TO THE GROWING MYOPIA CRISIS

With 50% of people worldwide estimated to be diagnosed with Myopia (nearsightedness) by 2050, understanding the condition and how to slow its progression early is critical.

DALLAS, June 16, 2022 /PRNewswire/ — All About Vision (AAV), the world’s leading online portal for vision and eye care information, has launched a myopia information hub. Myopia has rapidly increased in prevalence worldwide, with an estimated 50% of the global population diagnosed by 2050. The hub contains the most updated information on myopia with more than 100 pieces of content.

Myopia, also called nearsightedness, is an eye condition that makes distant objects look blurry. It usually develops in early childhood and can progress into early adulthood.

“Myopia currently is the number one condition in the visual system . . ., especially in younger-age adolescents,” said Doctor Maria Liu, Associate Professor of Clinical Optometry at UC Berkeley. “It is a complex condition that involves critical influence from both genetic and environmental factors. If left uncontrolled, myopia will cause excessive elongation of the eyeball, leading to retinal complications which can cause irreversible vision loss later in life.”

All About Vision worked with researchers from the International Myopia Institute, the WHO, the Brien Holden Vision Institute and others to incorporate the latest data to create accessible content for the myopia hub. Exclusive features include an interactive myopia simulator, which demonstrates what increasing levels of nearsightedness look like through a child’s eyes, and a myopia assessment to determine a child’s risk for having myopia.

“The mission for All About Vision is to ensure that visitors have the best information so they can make well-informed decisions for their children,” said Kim Schuy, Head of All About Vision. “With the growing prevalence of myopia, we are prepared to remain ahead of the curve to meet readers where they are in their search for information.”

To visit the Myopia Hub, visit https://www.allaboutvision.com/myopia/.

For information on All About Vision, visit https://www.allaboutvision.com/.

About All About Vision

Launched in 2000, All About Vision is a leading online resource for visual health and eye care topics. With 50 million annual visitors across 25 global markets, AAV turns evidence-based medical information into engaging, trustworthy content for readers covering  eye exams, vision correction, glaucoma, cataracts, myopia and more.

View original content to download multimedia:https://www.prnewswire.com/news-releases/all-about-vision-releases-comprehensive-information-hub-in-response-to-the-growing-myopia-crisis-301569478.html

SOURCE All About Vision

Staff

Recent Posts

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

48 mins ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

1 day ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

1 day ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

1 day ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

1 day ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

1 day ago